Calls Now Open
2026 Scholar-Innovator, Harrington Prize and ADDF-Harrington
Rare / Orphan, Oncology, Immunology
Epigenetically Enhanced Cell Therapy for Hodgkin's Lymphoma
2024 Oxford-Harrington Rare Disease Scholar
Full profile coming soon.
Become a part of our community and receive periodic communications with news and updates, as well as notifications of grant funding opportunities.